会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明专利
    • ATRIAL AND VENTRICULAR CAPTURE DETECTION AND THRESHOLD-SEEKING PACEMAKER
    • CA2196430A1
    • 1996-02-22
    • CA2196430
    • 1995-07-31
    • MEDTRONIC INC
    • MARKOWITZ H TOBYSTROEBEL JOHN CZHOU RENRUETER JOHN C
    • A61N1/368A61N1/37A61N1/372
    • Capture detection and stimulation threshold-measurement methods and apparatu s for deriving atrial and ventricular pace pulse (A-pace and V-pace) stimulati on energy strength-duration data. In a first atrial and ventricular threshold test regimen for use with patients having intact A-V conduction of first degree AV block, A-pace pulses are delivered at a test escape interval and A -V delay. Atrial loss of capture (ALOC) in response to an A-pace test stimulus is declared by the absence of a detected ventricular depolarization (V-event) i n the latter portion of the paced A-V delay interval following the delivery of the A-pace test stimulus. In the ventricular threshold test regimen, a V-pac e test stimulus is delivered after a shortened A-V delay. Ventricular loss of capture (VLOC) is declared by the detection of a V-event in the ventricular refractory period of the V-pace test stimulus. In a second algorithm for use in the atrium or ventricle in patients having regular measured sinus rhythm, premature A-pace or V-pace test stimuli are delivered, and the presence of a n A-event or V-event at the end of the measured sinus escape interval is declared to be ALOC or VLOC, respectively. A-pace and V-pace test stimuli ar e repeated to confirm capture declarations at an energy exceeding the LOC test energy. The atrial and ventricular stimulation threshold data derived by varying both pulse amplitude (strength) and width (duration) is stored in memory for telemetry out and analysis and for use in setting the V-pace and A- pace normal pulse width and amplitude used between successive auto-capture tests in order to conserve battery energy.
    • 73. 发明专利
    • Fault-tolerant elective replacement indication for implantable medical device
    • AU7093094A
    • 1995-01-24
    • AU7093094
    • 1994-05-10
    • MEDTRONIC INC
    • SHELTON MICHAEL BSTARKSON ROSS OSCHMIDT CRAIG LMARKOWITZ H TOBY
    • A61N1/37A61N1/378G01R31/36
    • A pacemaker having a fault-tolerant elective replacement indicator (ERI) triggering scheme in which transient excursions of parameters used as criteria for triggering ERI are rejected as triggering events. Periodic assessments of certain indicia of battery depletion are made, and subjected to a long-term low-pass filtering operation in order to reduce the effects of transient excursions of the indicia which result from non-ERI conditions. Over a long period of time (e.g., a day) predetermined threshold values of the indicia of interest must be exceeded a predetermined number of times in order for the device to issue an ERI. In one disclosed embodiment of the invention, the battery's terminal voltage and internal impedance are used as indicators of the battery's depletion level. Periodically, these values are measured and converted to digital values. The digital values are subjected to a low-pass filtering operation to prevent temporary or transient excursions of the impedance and voltage curves from causing ERI to be triggered. In another disclosed embodiment of the invention, a long term fading average of periodically measured values is maintained. When the measured values are found to fulfill the ERI criteria, assessment of the parameters of interest is performed at an increased rate. While assessments are performed at the increased rate, the continuously updated fading average value must fulfill the ERI triggering criteria at least a predetermined number of times before ERI is triggered. If the fading average fails to fulfill the ERI triggering criteria the required number of times, assessments are resumed at the first, slower periodic rate.
    • 74. 发明申请
    • METHOD AND DEVICE FOR DETECTING RESPIRATORY DISTURBANCES
    • 检测呼吸紊乱的方法和装置
    • WO2004062484A3
    • 2004-09-16
    • PCT/US2004000671
    • 2004-01-09
    • MEDTRONIC INC
    • CHO YOUNG KYUNLAWABNI ABED ESHELDON TODD JMARKOWITZ H TOBYSOWELAM SAMEHPITSCHNEIDER RAYLENE
    • A61B5/0205A61B5/08
    • A61B5/4818A61B5/0205A61B5/0809A61B5/0816
    • A system and method is disclosed for monitoring respiration including sensing a signal that varies with respiration, deriving a respiration parameter, applying criteria for detecting a respiration disturbance and determining one or more respiratory disturbance metrics. The system preferably includes an implantable sensor with an associated implantable medical device such that chronic respiration monitoring is possible. The implantable medical device may execute methods for detecting and measuring respiratory disturbances or may store data to be transferred to an external device for detecting and measuring respiratory disturbances. Respiratory disturbance detection may trigger a responsive action such as physiological data storage, a change in therapy, or a clinician warning. Assessment of cardiac function may be made on metrics of respiratory disturbances or a measure of circulatory delay time following detection of a respiratory disturbance.
    • 公开了一种用于监测呼吸的系统和方法,包括感测随呼吸变化的信号,导出呼吸参数,应用用于检测呼吸干扰的标准以及确定一个或多个呼吸干扰度量。 该系统优选地包括具有相关联的可植入医疗装置的可植入传感器,使得慢性呼吸监测是可能的。 可植入医疗设备可以执行用于检测和测量呼吸干扰的方法,或者可以存储要传送到外部设备以检测和测量呼吸干扰的数据。 呼吸紊乱检测可能会触发响应动作,如生理数据存储,治疗变化或临床医师警告。 心脏功能的评估可以根据呼吸紊乱度量或者在检测到呼吸紊乱之后的循环延迟时间量度来进行。
    • 75. 发明申请
    • REGULARIZATION OF VENTRICULAR RATE DURING ATRIAL TACHYARRHYTHMIA
    • 心律失常的心室速率的定量
    • WO0038782A9
    • 2002-04-11
    • PCT/US9930915
    • 1999-12-22
    • MEDTRONIC INC
    • IGEL DAVID AMARKOWITZ H TOBYBETZOLD ROBERT AKLECKNER KAREN JSCHROETTER JERAMY A
    • A61N1/362A61N1/368
    • A61N1/3622
    • A pacing system provided with a mode switching feature and ventricular rate regularization (VRR) function adapted to stabilize or regularize ventricular heart rate during chronic or paroxysmal atrial tachyarrhythmia. In a preferred embodiment, the pacing system nominally operates in an atrial synchronized pacing mode such as DDD or DDDR pacing mode. In response to detection of atrial rhythm characteristics consistent with an atrial tachyarrhythmia, e.g., atrial fibrillation, a mode switch into a non-atrial synchronized, ventricular rate regularization pacing mode, e.g. DDIR or VDIR pacing mode, is made. If the VRR function is programmed on, the ventricular pacing rate based upon a rate responsive sensor derived ventricular pacing rate modulated on a beat by beat basis by preceding intrinsic or paced ventricular events, the stability of the intrinsic ventricular heart rate, and any atrial pace events to regularize the ventricular pacing rate. The pacing system may also be permanently programmed to the DDIR pacing mode with the VRR feature functioning continuously. The pacing system may also be permanently programmed to the VVIR pacing mode with VRR function activated, but without consideration of atrial pace events.
    • 具有模式切换特征和心室率正常化(VRR)功能的起搏系统适于在慢性或阵发性房性快速性心律失常期间稳定或规范心室心率。 在优选实施例中,起搏系统名义地以心房同步起搏模式(例如DDD或DDDR起搏模式)操作。 响应于检测与房性快速性心律失常(例如心房颤动)一致的心房节律特征,模式切换到非心房同步的心室速率正则化起搏模式,例如心房颤动。 DDIR或VDIR起搏模式。 如果VRR功能被编程,则基于速率响应传感器导出的心室起搏速率的心室起搏速率通过先前的内在或节奏心室事件,内部心室心率的稳定性和任何心房起搏 事件来规范心室起搏率。 起搏系统也可以永久编程到DDIR起搏模式,VRR功能连续工作。 起搏系统也可以被永久编程到VVIR起搏模式,VRR功能被激活,但不考虑心房速度事件。